candoxatrilat has been researched along with candoxatril in 3 studies
| Studies (candoxatrilat) | Trials (candoxatrilat) | Recent Studies (post-2010) (candoxatrilat) | Studies (candoxatril) | Trials (candoxatril) | Recent Studies (post-2010) (candoxatril) |
|---|---|---|---|---|---|
| 46 | 10 | 1 | 62 | 29 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alabaster, CT; Machin, I; Samuels, GM; Sutton, MR | 1 |
| Wilkins, MR | 1 |
| Brearley, CJ; Cussans, NJ; Herron, M; Humphrey, MJ; Kaye, B; Mollatt, AR | 1 |
1 review(s) available for candoxatrilat and candoxatril
| Article | Year |
|---|---|
Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular disease.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Cyclohexanecarboxylic Acids; Diuretics; Drug Design; Heart Failure; Humans; Hypertension; Indans; Neprilysin; Propionates; Protease Inhibitors; Thiorphan | 1993 |
2 other study(ies) available for candoxatrilat and candoxatril
| Article | Year |
|---|---|
The effects of UK-79,300, an orally-absorbed atriopeptidase inhibitor, in a conscious dog model of cardiac insufficiency.
Topics: Animals; Cyclohexanecarboxylic Acids; Diuresis; Dogs; Heart Block; Indans; Indenes; Natriuresis; Neprilysin; Propionates; Stereoisomerism | 1989 |
Formation and pharmacokinetics of the active drug candoxatrilat in mouse, rat, rabbit, dog and man following administration of the prodrug candoxatril.
Topics: Absorption; Administration, Oral; Adult; Animals; Carbon Radioisotopes; Cyclohexanecarboxylic Acids; Dogs; Feces; Humans; Indans; Injections, Intravenous; Male; Mice; Middle Aged; Prodrugs; Propionates; Protease Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Species Specificity | 1997 |